SCHEMBL26698294

SCHEMBL26698294

CCC(=O)Oc1ccn(C)c(=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.46
HIF1A Q16665 3/20 0.45
KMT2A Q03164 3/20 0.45
ESR1 P03372 2/20 0.45
RECQL P46063 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
ELANE P08246 1/20 0.41
GAA P10253 2/20 0.41
USP2 O75604 2/20 0.41
HPGD P15428 2/20 0.41
GLA P06280 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14856800 0.81 HAO1 (0.38) KMT2AKDM4EHPGDMAPTPIK3C3
SCHEMBL26698236 0.81 LMNA (0.46) ACHEKMT2AALDH1A1KDM4EGAA
SCHEMBL27741946 0.76 MTNR1A (0.46) ACHEHIF1AKMT2AESR1RECQL
SCHEMBL27762475 0.76 MTNR1A (0.47) ACHEHIF1AKMT2AESR1RECQL
SCHEMBL27484101 0.74 KMT2A (0.49) ACHEHIF1AKMT2AESR1RECQL
SCHEMBL10782553 0.72 ACHE (0.71) ACHEHIF1AKMT2AESR1RECQL
SCHEMBL4810016 0.72 TUBB4A (0.47) RECQLSMN1; SMN2ALDH1A1KDM4EGAA
SCHEMBL31598867 0.72 TUBB4A (0.37) KMT2AKDM4EHPGDMAPTPIK3C3
SCHEMBL312147 0.71 KMT2A (0.76) ACHEHIF1AKMT2AESR1RECQL
SCHEMBL15721894 0.71 L3MBTL1 (0.47) KMT2AALDH1A1GAAUSP2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023226965-A1 ROCK INHIBITORS AND USES THEREOF DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2023-11-30 WO disclosed